Immunoglobulin M (IgM) Foretells Cardiovascular Complications

| Aug 19, 2009

One of the major complications of diabetes is diabetic nephropathy, a loss of kidney function that may lead to renal failure.  As kidney disease progresses, the barrier that keeps large molecules out of the urine, called the glomerular barrier, begins to break down.  With the barrier failing, certain large molecules begin to migrate into the urine. One of those hefty molecules is immunoglobulin M, or IgM.

Now Swedish researchers have found that type 1 patients with higher urine IgM levels are three times more likely to eventually die of a cardiovascular event or reach end-stage renal disease than patients with normal IgM levels.

(Although that sounds like pretty bad news, there is a silver lining to this dark cloud.) 

The research team, led by Omran Bakoush, MD, PhD, studied a group of 139 patients with type 1 diabetes. Their urine was sampled and their IgM levels were measured when they were recruited into the study in 1984. By the study's end in 2007, 32 of them had died of a cardiovascular event and 20 had reached end-stage renal disease. The analysis revealed that the patients with higher initial IgM levels in their urine were approximately three times more likely to die of a cardiovascular event or reach end-stage renal disease than those with lower levels.

(That's still a pretty dark cloud we have here. No sign of a silver lining yet, but just be patient.)

The patients with increased IgM who died of cardiovascular disease may have been victims of atherosclerosis. Atherosclerosis is the thickening and narrowing of blood vessels, caused by the accumulation of fatty material such as cholesterol.  The thickened artery walls slow the flow of blood and may eventually close completely, blocking vital blood flow to areas of the body.  When the system tries to compensate by forcing other arteries to carry more blood, a dangerous bubble, called an aneurysm, may develop in an artery and eventually burst. 

(It all still sounds pretty depressing.  But here, finally, is the good news.)

Atherosclerosis is treatable. 

In addition to a healthy diet and exercise, drugs called statins may be able to reverse the thickening of blood vessel walls.  If we know that high IgM levels indicate a patient who already has atherosclerosis, then we have a valuable tool to prevent, or at least reduce, the condition before symptoms appear.  Such patients, forewarned, could start a diet and exercise regimen and even consider taking statins.

And that's the silver lining.


Provisional abstract from BMC Medicine, published August 4, 2009

BioMed Central (2009, August 6). IgM In Urine Acts As Prognostic Indicator In Diabetes.

ScienceDaily. Retrieved August 10, 2009

Click Here To View Or Post Comments

Categories: Community, Diabetes, Diabetes, Heart Care & Heart Disease, Kidney Care (Nephropathy), Losing weight, Medications, Research, Type 1 Issues, Type 2 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (1)

You May Also Be Interested In...


Posted by Anonymous on 26 August 2009

OK, but what about those with Type 1 who develop cardiovascular disease or thickening of the arteries WITHOUT elevated cholesterol? Many Type 1's are thin, eat healthy, exercise, have excellent cholesterol levels without drugs, have high HDL (good/protective cholesterol), low triglycerides, normal kidney function, and yet STILL have inflammation and thick arteries? We've seen this is children's studies, after only a few years of T1 diabetes. Many people with autoimmune diseases have this issue as well, such as Lupus. It's the autoimmunity and inflammation in Type 1 that is causing heart disease in these cases. And no one is doing a thing to recognize this, let alone fix it. Drugs used to treat primarily Type 2's (typically overweight and with high cholesterol) are not always the answer for us Type 1s. For years doctors have pushed expensive BP meds on those with normal BP to 'protect their kidneys' but now new studies have found no such effect. Some have side effects, and who knows if long term use from a young age is safe.

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.